Literature DB >> 8040335

Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

N Bhardwaj1, A Bender, N Gonzalez, L K Bui, M C Garrett, R M Steinman.   

Abstract

Antigen-specific, CD8+, cytolytic T lymphocytes (CTLs) could potentially provide resistance to several infectious and malignant diseases. However, the cellular requirements for the generation of specific CTLs in human lymphocyte cultures are not well defined, and repetitive stimulation with antigen is often required. We find that strong CD8+ CTL responses to influenza virus can be generated from freshly isolated blood T cells, as long as dendritic cells are used as antigen presenting cells (APCs). Small numbers of dendritic cells (APC:T cell ratio of 1:50-1:100) induce these CTL responses from most donors in 7 d of culture, but monocytes are weak or inactive. Whereas both dendritic cells and monocytes are infected with influenza virus, the former serve as effective APCs for the induction of CD8+ T cells while the latter act as targets for the CTLs that are induced. The strong CD8+ response to influenza virus-infected dendritic cells is accompanied by extensive proliferation of the CD8+ T cells, but the response can develop in the apparent absence of CD4+ helpers or exogenous lymphokines. CD4+ influenza virus-specific CTLs can also be induced by dendritic cells, but the cultures initially must be depleted of CD8+ cells. These findings should make it possible to use dendritic cells to generate human, antigen-specific, CD8+ CTLs to other targets. The results illustrate the principle that efficient T cell-mediated responses develop in two stages: an afferent limb in which dendritic cells are specialized APCs and an efferent limb in which the primed T cells carry out an immune response to many types of presenting cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040335      PMCID: PMC296160          DOI: 10.1172/JCI117399

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  71 in total

1.  Frequency of herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen- and antigen-driven primary in vitro T cell responses.

Authors:  H Hengel; M Lindner; H Wagner; K Heeg
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

2.  Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells.

Authors:  J W Young; R M Steinman
Journal:  Cell Immunol       Date:  1988-01       Impact factor: 4.868

3.  Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.

Authors:  W M Kast; C J Boog; B O Roep; A C Voordouw; C J Melief
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

4.  Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.

Authors:  S R Riddell; K S Watanabe; J M Goodrich; C R Li; M E Agha; P D Greenberg
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

5.  Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells.

Authors:  R M Buller; K L Holmes; A Hügin; T N Frederickson; H C Morse
Journal:  Nature       Date:  1987 Jul 2-8       Impact factor: 49.962

6.  Limiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products.

Authors:  M Wysocka; J R Bennink
Journal:  Cell Immunol       Date:  1988-04-01       Impact factor: 4.868

7.  Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.

Authors:  S E Townsend; J P Allison
Journal:  Science       Date:  1993-01-15       Impact factor: 47.728

8.  Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells.

Authors:  K Inaba; J W Young; R M Steinman
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

9.  MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations.

Authors:  P G Holt; M A Schon-Hegrad; J Oliver
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

10.  Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.

Authors:  R P Johnson; A Trocha; T M Buchanan; B D Walker
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  72 in total

1.  Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

Authors:  M V Dhodapkar; R M Steinman; M Sapp; H Desai; C Fossella; J Krasovsky; S M Donahoe; P R Dunbar; V Cerundolo; D F Nixon; N Bhardwaj
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

2.  Dendritic cells: at the clinical crossroads.

Authors:  J J Mulé
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

3.  CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome.

Authors:  G Xanthou; N I Tapinos; M Polihronis; I P Nezis; L H Margaritis; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 4.  Dendritic cells: a link between innate and adaptive immunity.

Authors:  K Palucka; J Banchereau
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

Review 5.  Active immunization of humans with dendritic cells.

Authors:  M V Dhodapkar; N Bhardwaj
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

6.  Dendritic cells as effector cells: gamma interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication.

Authors:  F Aline; D Bout; I Dimier-Poisson
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

7.  Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.

Authors:  Gavin Morrow; Barry Slobedman; Anthony L Cunningham; Allison Abendroth
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro.

Authors:  C J Kim; T Prevette; J Cormier; W Overwijk; M Roden; N P Restifo; S A Rosenberg; F M Marincola
Journal:  J Immunother       Date:  1997-07       Impact factor: 4.456

9.  Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions.

Authors:  Sara Gredmark; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  MHC class I and II peptide homology regulates the cellular immune response.

Authors:  Matthew M Halpert; Vanaja Konduri; Dan Liang; Jonathan Vazquez-Perez; Colby J Hofferek; Scott A Weldon; Yunyu Baig; Indira Vedula; Jonathan M Levitt; William K Decker
Journal:  FASEB J       Date:  2020-04-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.